Weight Loss and GLP-1 Agonists

Obesity is a serious and common health issue that was misunderstood for a very long time. In fact, the American Medical Association did not recognize it as a disease until 2013! In the years since, much more has been learned about this chronic disease and how to treat it. Let’s start out by defining obesity.

If a person’s weight is more than what is considered healthy based on their height, it is classified as overweight or obesity. A person’s body mass index (BMI) is used as a screening tool for overweight and obesity.

Adults with a BMI of 30 or higher are considered to have obesity.

What causes obesity?

Obesity rarely has a single cause. However, a few factors may contribute to its development including:

Genetics

An unhealthy
diet

Lack of physical
activity

Certain disease
and medications

Community
environment

How can obesity be addressed?

Following a healthy
meal plan

Getting physical
activity

Sleep

Reduce stress levels

What if lifestyle changes aren’t helping your patient reach weight-loss goals?

For a huge swath of the US population, about 40%, there now exists a therapeutic approach outside of surgery, known as GLP-1 agonists, that could improve the weight loss journey. GLP-1s could help patient’s achieve lower BMI.

Clinical studies have demonstrated 5%-15% weight loss on average in patients using the medication as directed and in the setting of comprehensive support for weight loss.

What this 1-day workshop will cover:

How to safely dose and monitor your patient’s weight loss

How to recognize non responding patients and what to do next

How to support your patient’s weight loss with GLP1s and supplements